Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. uri icon

authors

  • Sendaydiego, Xavier
  • Jarvik, Jeffrey G
  • Singh, Siddharth
  • Liew, Jean W
  • Namrata Singh, MD MSCI
  • Gold, Laura S
  • Dubreuil, Maureen
  • Andrews, James S
  • Reid, Pankti
  • Liew, David F L
  • Goulabchand, Radjiv
  • Hughes, Grant C
  • Sparks, Jeffrey A

publication date

  • June 1, 2025